Reports for APOTEX INC

Formerly known as AA PHARMA INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

220 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

3124 (93%)

3354

Discontinuation Reports

To be discontinued:

26 (7%)

Discontinued:

343 (93%)

Reversed:

0 (0%)

369

145 (4%)

73 (30%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LEVETIRACETAM 250MG TABLET Resolved 2018-03-05 2018-06-08 41852
APO-LEVETIRACETAM 500MG TABLET Resolved 2022-06-27 2022-08-24 163448
APO-LEVETIRACETAM 750MG TABLET Resolved 2018-12-12 2018-12-21 69307
APO-LEVETIRACETAM 750MG TABLET Resolved 2022-11-20 2022-12-23 175321
APO-LEVETIRACETAM 500MG TABLET Resolved 2019-03-13 2019-05-03 78526
APO-LEVOBUNOLOL OPHTHALMIC SOLUTION USP 0.25% 0.25% LIQUID Actual shortage 2017-08-13 2017-10-05 19096
APO-LEVOBUNOLOL OPHTHALMIC SOLUTION USP 0.5% 0.5% LIQUID Actual shortage 2017-08-13 2017-10-05 19093
APO-LEVOCARB - TAB 25MG/250MG 25MG 250MG TABLET Resolved 2021-03-26 2021-05-10 136403
APO-LEVOCARB - TAB 25MG/250MG 25MG 250MG TABLET Resolved 2020-12-28 2021-02-22 130710
APO-LEVOCARB - TAB 25MG/250MG 25MG 250MG TABLET Resolved 2017-08-23 2017-11-09 20108
APO-LEVOCARB - TAB 25MG/250MG 25MG 250MG TABLET Resolved 2017-10-03 2017-11-09 24265
APO-LEVOCARB - TAB 25MG/250MG 25MG 250MG TABLET Resolved 2019-02-06 2019-03-01 74911
APO-LEVOCARB-TAB 25MG/100MG 25MG 100MG TABLET Resolved 2019-02-06 2019-02-25 74894
APO-LEVOCARB-TAB 25MG/100MG 25MG 100MG TABLET Resolved 2019-02-06 2019-02-25 74896
APO-LEVOCARB-TAB 25MG/100MG 25MG 100MG TABLET Resolved 2021-02-19 2021-03-15 134436
APO-LEVOCARB-TAB 25MG/100MG 100MG 25MG TABLET Resolved 2023-03-23 2023-04-06 187718
APO-LEVOCARB-TAB 25MG/100MG 100MG 25MG TABLET Resolved 2023-04-14 2023-05-06 189632
APO-LEVOCARB-TAB 25MG/100MG 100MG 25MG TABLET Resolved 2022-05-06 2022-05-19 160138
APO-LEVOCARB-TAB 25MG/100MG 25MG 100MG TABLET Resolved 2020-09-09 2020-09-21 123939
APO-LEVOCARB-TAB 25MG/100MG 100MG 25MG TABLET Resolved 2024-08-15 2024-10-04 235339
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FENTANYL MATRIX 25MCG PATCH Discontinued 2018-09-07 2018-09-15 60489
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497
APO-FENTANYL MATRIX 100MCG PATCH Discontinued 2018-02-23 2018-12-28 40741
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-FLUVOXAMINE TABLETS 100MG TABLET Discontinued 2017-03-30 2018-02-05 4713
APO-FLUVOXAMINE TABLETS 50MG TABLET Discontinued 2017-03-30 2018-02-05 4716
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110968
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110971